Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling

Figure 2

Transducin (β)-like 1 X-linked receptor 1 (TBLR1) is upregulated in archived breast cancer tissues. (A) Representative immunohistochemistry fluorescent micrographs showing TBLR1 expression levels in normal and tumor breast tissue samples from cases with different clinical stages (I to IV); magnification, 200× and 400×. (B) Quantification analyses of mean TBLR1 expression levels in normal breast tissues (n = 3) and breast tumor tissues from cases with different clinical stages (n =16/stage); MOD, mean optical density. (C) Kaplan-Meier survival curves comparing cumulative overall survival rates in patients with low and high TBLR1 expression levels. (D) Survival curves for breast cancer patients with clinical stage I to II (left) and clinical stage III to IV (right) disease.

Back to article page